Nika Pharmaceuticals (OTCQB: NIKA) Advances Immune-Based Drug Portfolio Targeting HIV, Cancer, and Chronic Diseases
Nika Pharmaceuticals, Inc. (OTCQB: NIKA), a next-generation biopharmaceutical company focused on immune-strengthening therapeutics, is emerging as a compelling investment opportunity in the global fight against HIV/AIDS, Hepatitis B and C,…
